146 related articles for article (PubMed ID: 35180929)
1. Intracellular and extracelluar cyclic GMP in the brain and the hippocampus.
Taoro-González L; Cabrera-Pastor A; Sancho-Alonso M; Felipo V
Vitam Horm; 2022; 118():247-288. PubMed ID: 35180929
[TBL] [Abstract][Full Text] [Related]
2. Extracellular cGMP Reverses Altered Membrane Expression of AMPA Receptors in Hippocampus of Hyperammonemic Rats: Underlying Mechanisms.
Taoro-Gonzalez L; Arenas YM; Cabrera-Pastor A; Felipo V
Mol Neurobiol; 2019 Jun; 56(6):4428-4439. PubMed ID: 30328550
[TBL] [Abstract][Full Text] [Related]
3. In vivo administration of extracellular cGMP normalizes TNF-α and membrane expression of AMPA receptors in hippocampus and spatial reference memory but not IL-1β, NMDA receptors in membrane and working memory in hyperammonemic rats.
Cabrera-Pastor A; Hernandez-Rabaza V; Taoro-Gonzalez L; Balzano T; Llansola M; Felipo V
Brain Behav Immun; 2016 Oct; 57():360-370. PubMed ID: 27189036
[TBL] [Abstract][Full Text] [Related]
4. Increasing extracellular cGMP in cerebellum in vivo reduces neuroinflammation, GABAergic tone and motor in-coordination in hyperammonemic rats.
Cabrera-Pastor A; Balzano T; Hernández-Rabaza V; Malaguarnera M; Llansola M; Felipo V
Brain Behav Immun; 2018 Mar; 69():386-398. PubMed ID: 29288802
[TBL] [Abstract][Full Text] [Related]
5. Sequential activation of soluble guanylate cyclase, protein kinase G and cGMP-degrading phosphodiesterase is necessary for proper induction of long-term potentiation in CA1 of hippocampus. Alterations in hyperammonemia.
Monfort P; Muñoz MD; Kosenko E; Llansola M; Sánchez-Pérez A; Cauli O; Felipo V
Neurochem Int; 2004 Nov; 45(6):895-901. PubMed ID: 15312984
[TBL] [Abstract][Full Text] [Related]
6. Blocking glycine receptors reduces neuroinflammation and restores neurotransmission in cerebellum through ADAM17-TNFR1-NF-κβ pathway.
Arenas YM; Cabrera-Pastor A; Juciute N; Mora-Navarro E; Felipo V
J Neuroinflammation; 2020 Sep; 17(1):269. PubMed ID: 32917219
[TBL] [Abstract][Full Text] [Related]
7. Hyperammonemia impairs long-term potentiation in hippocampus by altering the modulation of cGMP-degrading phosphodiesterase by protein kinase G.
Monfort P; Muñoz MD; Felipo V
Neurobiol Dis; 2004 Feb; 15(1):1-10. PubMed ID: 14751765
[TBL] [Abstract][Full Text] [Related]
8. Neuroinflammation increases GABAergic tone and impairs cognitive and motor function in hyperammonemia by increasing GAT-3 membrane expression. Reversal by sulforaphane by promoting M2 polarization of microglia.
Hernandez-Rabaza V; Cabrera-Pastor A; Taoro-Gonzalez L; Gonzalez-Usano A; Agusti A; Balzano T; Llansola M; Felipo V
J Neuroinflammation; 2016 Apr; 13(1):83. PubMed ID: 27090509
[TBL] [Abstract][Full Text] [Related]
9. Gastrodin promotes hippocampal neurogenesis via PDE9-cGMP-PKG pathway in mice following cerebral ischemia.
Xiao H; Jiang Q; Qiu H; Wu K; Ma X; Yang J; Cheng O
Neurochem Int; 2021 Nov; 150():105171. PubMed ID: 34419525
[TBL] [Abstract][Full Text] [Related]
10. Chronic hyperammonemia alters extracellular glutamate, glutamine and GABA and membrane expression of their transporters in rat cerebellum. Modulation by extracellular cGMP.
Cabrera-Pastor A; Arenas YM; Taoro-Gonzalez L; Montoliu C; Felipo V
Neuropharmacology; 2019 Dec; 161():107496. PubMed ID: 30641078
[TBL] [Abstract][Full Text] [Related]
11. A critical role of NO/cGMP/PKG dependent pathway in hippocampal post-ischemic LTP: modulation by zonisamide.
Costa C; Tozzi A; Siliquini S; Galletti F; Cardaioli G; Tantucci M; Pisani F; Calabresi P
Neurobiol Dis; 2011 Nov; 44(2):185-91. PubMed ID: 21749921
[TBL] [Abstract][Full Text] [Related]
12. Hyperammonemia alters glycinergic neurotransmission and modulation of the glutamate-nitric oxide-cGMP pathway by extracellular glycine in cerebellum in vivo.
Cabrera-Pastor A; Taoro-Gonzalez L; Felipo V
J Neurochem; 2016 May; 137(4):539-48. PubMed ID: 26875688
[TBL] [Abstract][Full Text] [Related]
13. Regulation of hippocampal cGMP levels as a candidate to treat cognitive deficits in Huntington's disease.
Saavedra A; Giralt A; Arumí H; Alberch J; Pérez-Navarro E
PLoS One; 2013; 8(9):e73664. PubMed ID: 24040016
[TBL] [Abstract][Full Text] [Related]
14. Role of extracellular cGMP and of hyperammonemia in the impairment of learning in rats with chronic hepatic failure. Therapeutic implications.
Erceg S; Monfort P; Cauli O; Montoliu C; Llansola M; Piedrafita B; Felipo V
Neurochem Int; 2006; 48(6-7):441-6. PubMed ID: 16497413
[TBL] [Abstract][Full Text] [Related]
15. Hyperammonemia Enhances GABAergic Neurotransmission in Hippocampus: Underlying Mechanisms and Modulation by Extracellular cGMP.
Sancho-Alonso M; Garcia-Garcia R; Teruel-Martí V; Llansola M; Felipo V
Mol Neurobiol; 2022 Jun; 59(6):3431-3448. PubMed ID: 35320456
[TBL] [Abstract][Full Text] [Related]
16. Molecular mechanisms of the alterations in NMDA receptor-dependent long-term potentiation in hyperammonemia.
Monfort P; Muñoz MD; Felipo V
Metab Brain Dis; 2005 Dec; 20(4):265-74. PubMed ID: 16382337
[TBL] [Abstract][Full Text] [Related]
17. Restoration of learning ability in hyperammonemic rats by increasing extracellular cGMP in brain.
Erceg S; Monfort P; Hernandez-Viadel M; Llansola M; Montoliu C; Felipo V
Brain Res; 2005 Mar; 1036(1-2):115-21. PubMed ID: 15725408
[TBL] [Abstract][Full Text] [Related]
18. Cyclic GMP pathways in hepatic encephalopathy. Neurological and therapeutic implications.
Montoliu C; Rodrigo R; Monfort P; Llansola M; Cauli O; Boix J; Elmlili N; Agusti A; Felipo V
Metab Brain Dis; 2010 Mar; 25(1):39-48. PubMed ID: 20195723
[TBL] [Abstract][Full Text] [Related]
19. Hyperammonemia induces glial activation, neuroinflammation and alters neurotransmitter receptors in hippocampus, impairing spatial learning: reversal by sulforaphane.
Hernández-Rabaza V; Cabrera-Pastor A; Taoro-González L; Malaguarnera M; Agustí A; Llansola M; Felipo V
J Neuroinflammation; 2016 Feb; 13():41. PubMed ID: 26883214
[TBL] [Abstract][Full Text] [Related]
20. Extracellular Protein Kinase A Modulates Intracellular Calcium/Calmodulin-Dependent Protein Kinase II, Nitric Oxide Synthase, and the Glutamate-Nitric Oxide-cGMP Pathway in Cerebellum. Differential Effects in Hyperammonemia.
Cabrera-Pastor A; Llansola M; Felipo V
ACS Chem Neurosci; 2016 Dec; 7(12):1753-1759. PubMed ID: 27673574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
